Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jeremy M. Shefner, Ammar Al-Chalabi, Jinsy A. Andrews, Adriano Chio, Mamede De Carvalho, Bettina M. Cockroft, Philippe Corcia, Philippe Couratier, Merit E. Cudkowicz, Angela Genge, Orla Hardiman, Terry Heiman-Patterson, Robert D. Henderson, Caroline Ingre, Carlayne E. Jackson, Wendy Johnston, Noah Lechtzin, Albert Ludolph, Nicholas J. Maragakis, Timothy M. Miller, Jesus S. Mora Pardina, Susanne Petri, Zachary Simmons, Leonard H. Van Den Berg, Lorne Zinman, Stuart Kupfer, Fady I. Malik, Lisa Meng, Tyrell J. Simkins, Jenny Wei, Andrew A. Wolff & Stacy A. Rudnicki. (2023) COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:5-6, pages 523-534.
Read now
Read now
. (2022) Theme 12 - Clinical Management and Support. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:sup1, pages 176-194.
Read now
Read now
Articles from other publishers (2)
Adriaan D de Jongh, Nathalie Braun, Markus Weber, Michael A van Es, Pegah Masrori, Jan H Veldink, Philip van Damme, Leonard H van den Berg & Ruben P A van Eijk. (2022) Characterising ALS disease progression according to El Escorial and Gold Coast criteria. Journal of Neurology, Neurosurgery & Psychiatry 93:8, pages 865-870.
Crossref
Crossref
Jochem Helleman, Jaap N. E. Bakers, Evelien Pirard, Leonard H. van den Berg, Johanna M. A. Visser-Meily & Anita Beelen. (2022) Home-monitoring of vital capacity in people with a motor neuron disease. Journal of Neurology 269:7, pages 3713-3722.
Crossref
Crossref